What The Facts: Stem cells with Cynata Therapeutics
theaustralian.com.au
What The Facts: Stem cells with Cynata Therapeutics
What are stem cell therapies, when has the technology developed, how is it being advanced, and where is it going?
1 month ago
Cynapsus Therapeutics Stock
Summit Therapeutics Inc. Stock (SMMT) - Quote Nasdaq- MarketScreener
Summit Therapeutics Inc. Stock (SMMT) - Quote Nasdaq- MarketScreener
marketscreener.com
Jan 18, 2017
Aileron Therapeutics, Inc. will Change its Ticker to RNTX from ALRN
Aileron Therapeutics, Inc. will Change its Ticker to RNTX from ALRN
marketscreener.com
Jan 12, 2025
Stoke Therapeutics | LinkedIn
Stoke Therapeutics | LinkedIn
linkedin.com
Apr 27, 2024
Top videos
Cynata Therapeutics Limited Receives Approval from the UK Medicines and Healthcare Products Regulatory Agency to Proceed with Its Phase 2 Clinical Trial of the Cymerustm Mesenchymal Stem Cell Product CYP-002 in Patients with Critical Limb Ischaemia
Cynata Therapeutics Limited Receives Approval from the UK Medicines and Healthcare Products Regulatory Agency to Proceed with Its Phase 2 Clinical Trial of the Cymerustm Mesenchymal Stem Cell Product CYP-002 in Patients with Critical Limb Ischaemia
marketscreener.com
Jan 13, 2020
🧬 Exciting news from Australian biotech! Cynata Therapeutics just completed their Phase 3 trial for a groundbreaking stem cell treatment that could help over 600 million people worldwide suffering from knee osteoarthritis. Imagine getting relief from chronic knee pain with just one injection - no more daily medications or repeated treatments. This could be a game-changer for anyone who's watched a loved one struggle with joint pain. Do you know someone who could benefit from this kind of breakt
1:34
🧬 Exciting news from Australian biotech! Cynata Therapeutics just completed their Phase 3 trial for a groundbreaking stem cell treatment that could help over 600 million people worldwide suffering from knee osteoarthritis. Imagine getting relief from chronic knee pain with just one injection - no more daily medications or repeated treatments. This could be a game-changer for anyone who's watched a loved one struggle with joint pain. Do you know someone who could benefit from this kind of breakt
FacebookStockWire X
66 views5 months ago
Cynata Therapeutics (ASX:CYP): ASX Gems | Cynata Therapeutics
Cynata Therapeutics (ASX:CYP): ASX Gems | Cynata Therapeutics
linkedin.com
4.5K views5 months ago
Cynapsus Therapeutics Parkinsons Drug
Elevar Therapeutics announces FDA acceptance for review of new drug application for lirafugratinib
Elevar Therapeutics announces FDA acceptance for review of new drug application for lirafugratinib
marketscreener.com
1 month ago
Understanding Ropinirole: Dosage, Usage, & More
0:48
Understanding Ropinirole: Dosage, Usage, & More
TikTokprofessional.drug.dealer
42.5K viewsSep 18, 2020
“It has the potential to stop or slow Parkinson’s.” NRG Therapeutics has secured an impressive £50 million to advance their drug, NRG5051, into clinical trials for people with Parkinson’s. The Parkinson’s UK Virtual Biotech originally invested £1 million in 2019, and is now working in partnership with the Parkinson's Foundation. Dr Lynsey Bilsland is here to tell you more about the drug, how we remain an active founding investor and the next steps. | Parkinson's UK
1:56
“It has the potential to stop or slow Parkinson’s.” NRG Therapeutics has secured an impressive £50 million to advance their drug, NRG5051, into clinical trials for people with Parkinson’s. The Parkinson’s UK Virtual Biotech originally invested £1 million in 2019, and is now working in partnership with the Parkinson's Foundation. Dr Lynsey Bilsland is here to tell you more about the drug, how we remain an active founding investor and the next steps. | Parkinson's UK
FacebookParkinson's UK
37.5K views8 months ago
Cynata Therapeutics Limited Receives Approval from the UK Medicines and Healthcare Products Regulatory Agency to Proceed with Its Phase 2 Clinical Trial of the Cymerustm Mesenchymal Stem Cell Product CYP-002 in Patients with Critical Limb Ischaemia
Cynata Therapeutics Limited Receives Approval from the UK M…
Jan 13, 2020
marketscreener.com
🧬 Exciting news from Australian biotech! Cynata Therapeutics just completed their Phase 3 trial for a groundbreaking stem cell treatment that could help over 600 million people worldwide suffering from knee osteoarthritis. Imagine getting relief from chronic knee pain with just one injection - no more daily medications or repeated treatments. This could be a game-changer for anyone who's watched a loved one struggle with joint pain. Do you know someone who could benefit from this kind of breakt
1:34
🧬 Exciting news from Australian biotech! Cynata Therapeutics just …
66 views5 months ago
FacebookStockWire X
Cynata Therapeutics (ASX:CYP): ASX Gems | Cynata Therapeutics
Cynata Therapeutics (ASX:CYP): ASX Gems | Cynata Therapeutics
4.5K views5 months ago
linkedin.com
Cynata Therapeutics : trois programmes actifs devraient générer des catalyseurs majeurs dans les prochains trimestres, selon Euroz Hartleys
Cynata Therapeutics : trois programmes actifs devraient géné…
6 months ago
zonebourse.com
Cynata completes strategic review of development portfolio
Cynata completes strategic review of development portfolio
13 viewsJul 26, 2023
proactiveinvestors.com.au
Cynata Therapeutics Limited Completes Patient Enrolment in Phase 2 aGvHD Clinical Trial
Cynata Therapeutics Limited Completes Patient Enrolment in P…
5 months ago
marketscreener.com
Cynata Therapeutics opens first US site in Phase 2 CYP-001 trial
Cynata Therapeutics opens first US site in Phase 2 CYP-001 trial
10 viewsNov 15, 2023
proactiveinvestors.com.au
Cynata secures $1.5m placement funding
3 weeks ago
theaustralian.com.au
3:30
BioScience Managers and Cynata – delivering ground-breaking stem c…
192 views2 months ago
YouTubeDepartment of Industry, Science and Resources
Cynata Therapeutics stem cell technology
Aug 19, 2022
adelaidenow.com.auBrad Crouch
1:02:29
Dr. Kilian Kelly, Ph.D. - CEO, Cynata Therapeutics - iPSC-Derived, Mes…
1.9K viewsApr 8, 2025
YouTubeProgress, Potential, and Possibilities
Company - Intensity Therapeutics
Feb 10, 2021
intensitytherapeutics.com
13:48
Cynata Therapeutics
99 views4 months ago
YouTubeAlliance for Regenerative Medicine
Combined Therapeutics | LinkedIn
Jan 12, 2018
linkedin.com
Cytovia Therapeutics | LinkedIn
Sep 10, 2019
linkedin.com
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal
6 months ago
wsj.com
6:52
Cynata Therapeutics: Stem cell therapies entering the market
1 month ago
YouTubeStockhead
Dualitas Therapeutics | LinkedIn
8 months ago
linkedin.com
5:40
Turning Point Therapeutics CEO on the company's successful IPO
Dec 13, 2019
CNBC
2:16
If you’re considering gene therapy, watch this video to better underst…
831.5K viewsJan 8, 2024
FacebookSarepta Therapeutics
30:47
Cynata Therapeutics (ASX:CYP) with Dr Kilian | Webinar | 09/12/25
124 views5 months ago
YouTubeSharewise
Cybrexa Therapeutics | LinkedIn
Apr 10, 2021
linkedin.com
0:30
Learn about the newest option available to treat Duchenne musc…
19.2K viewsApr 8, 2021
FacebookSarepta Therapeutics
Yumanity Therapeutics Announces Definitive Agreements for Two Str…
Jun 6, 2022
globenewswire.com
Sarepta Therapeutics | LinkedIn
Jul 21, 2012
linkedin.com
0:20
Acuitas Therapeutics lipid nanoparticles used in Pfizer-BioN…
16.7K viewsDec 14, 2020
YahooYahoo News Canada Video
Private Equity
9 months ago
WSJColin Kellaher
Intellia Therapeutics, Inc.: Intellia Therapeutics Announces FDA Reg…
Nov 25, 2024
finanznachrichten.de
1:55
The future of regenerative medicine
May 8, 2017
CNBC
See more videos
Static thumbnail place holder